New drugs 05, part I.
In this article, you'll learn about nine new drugs, including: Prussian blue, which could protect people from radiation exposure following an act of biochemical terrorism. Bevacizumab, a new monoclonal antibody and the first angiogenesis inhibitor for colorectal cancer. Cinacalcet HCl, the first calcimimetic drug for treating hyperparathyroidism. Unless otherwise specified, the information in the following summaries applies to adults, not children. Consult the package insert for information about each drug's safety during pregnancy and breast-feeding. Also consult the package insert, a pharmacist, or a comprehensive drug reference for more details on precautions, drug interactions, and adverse reactions for all these drugs.
Hussar
Daniel A
DA
Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA, USA.
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000931:Antidotes / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000068258:Bevacizumab; D000069449:Cinacalcet; D004358:Drug Therapy / Q000451:nursing; D064420:Drug-Related Side Effects and Adverse Reactions; D005295:Ferrocyanides / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006961:Hyperparathyroidism / Q000188:drug therapy; D009281:Naphthalenes / Q000009:adverse effects / Q000627:therapeutic use; D004364:Pharmaceutical Preparations
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000931:Antidotes; D000970:Antineoplastic Agents; D005295:Ferrocyanides; D009281:Naphthalenes; D004364:Pharmaceutical Preparations; D000068258:Bevacizumab; C000170:ferric ferrocyanide; D000069449:Cinacalcet